ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO705

Analysis of Underlying Diseases Associated with Kidney Stones in Korean Children and Adolescents

Session Information

  • Pediatric Nephrology - 1
    October 25, 2024 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Pediatric Nephrology

  • 1900 Pediatric Nephrology

Authors

  • Cho, Heeyeon, Samsung Medical Center, Gangnam-gu, Seoul, Korea (the Republic of)
  • Joung, Jinwoon, Samsung Medical Center, Gangnam-gu, Seoul, Korea (the Republic of)
Background

Recently, the prevalence of kidney stones occurring in children and adolescents is increasing worldwide. The renal stones may appear as the clinical manifestations of underlying diseases or as a complication of the treatment. Therefore, this study aimed to analyze the underlying diseases including genetic causes and assess clinical outcomes of Korean children with nephrolithiasis.

Methods

From January 2022 to December 2023, we retrospectively analyzed demographic data for patients aged 0 to 18 who were newly diagnosed with kidney stones using ultrasonography who visited Samsung Medical Center. Medical records including sex, gestational age, underlying disease, medication history, genetic analysis, and ultrasonography were retrospectively reviewed. The authors reviewed whether there was the underlying diseases or interventions related to kidney stones, and if such an underlying disease was not confirmed at the time of diagnosis, a genetic test such as whole exome sequencing was performed to distinguish hereditary kidney disease.

Results

A total of 102 patients were diagnosed with kidney stones, and the male to female ratio was 1.04. The average age at diagnosis was 76 months. The underlying diseases were prematurity (45.0 %), tubulopathy after chemotherapy in pediatric patients with malignancy (13.8 %), hereditary disease confirmed through genetic testing (13.8%), and congenital anomalies of the kidney and urinary tract (CAKUT) with hydronephrosis or cyst (12.7%). In addition, underlying diseases such as congenital heart disease requiring diuretic treatment (5.9%), epilepsy taking anti-seizure medication that cause stones (3.9%), and inflammatory bowel disease (2.9%) were found. There were two cases in which these underlying diseases were not found. There were 2 cases that required urological surgery, and 1 case had renal function decline of chronic kidney disease stage 3.

Conclusion

This study suggests that kidney stone may appear in association with various underlying diseases and be a clinical clue of hereditary disease. Therefore, the screening for stone in patients with relevant underlying disease or the active evaluation of the genetic cause should be considered. The prognosis for surgery or decline in renal function is relatively favorable.